NBIX (Neurocrine Biosciences Inc) Projected Sales Volume

Graphic logo of Neurocrine (NBIX)

Neurocrine Biosciences (NBIX) relies on the dominance of Ingrezza in dyskinesia therapy and the success of new molecules. Sales of this drug are accelerating capital inflows, confirming the company's potential sales volume, where the current value equals 5.10. However, geopolitical tensions are hindering international research and the procurement of chemical raw materials, creating logistics risks for neurobiological products.

Company Revenue Forecast: Neurocrine Corp (NBIX) for 07/04/2022 - 11/18/2026

Financial and market metric breakdowns for Neurocrine Biosciences Inc (NBIX)

General company analysis:Neurocrine
Product sample of Neurocrine

The scale of Neurocrine Biosciences (NBIX) operations amidst fierce competition with pharma behemoths makes the company's projected sales level a key indicator of commercial viability. This metric aggregates the market value of future revenues, allowing investors to identify hidden anomalies in strategy execution through the analysis of daily price action and assess the actual capital density ensuring business resilience in a high-risk environment.

Main competitors

Company Future Sales Volume BIIB (Biogen)|Company Projected Revenue RGC (Regencell Bioscience Ltd)|Axsome Therapeutics, Inc. - Company Future Sales Volume|ACAD (ACADIA Pharmaceuticals Inc) - Company Expected Revenue|Xenon Corp - Projected Sales Volume|Company Future Revenue VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Company Projected Revenue|Company Expected Revenue CPRX (Catalyst Pharmaceuticals, Inc.)|Company Projected Revenue Denali Therapeutics Inc|Company Expected Sales Volume Harmony Corp HRMY|Projected Sales Volume BHVN|Company Future Sales Volume Amylyx Pharmaceuticals AMLX|Projected Sales Volume TRVI (Trevi Corp)|Company Future Sales Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Projected Sales Volume|CeriBell Corp (CBLL) - Company Future Sales Volume|Prothena Corp (PRTA) - Company Projected Revenue|Company Expected Sales Volume Alector Inc. (ALEC)|Company Future Sales Volume ANNX|omeros.com (OMER) - Company Future Sales|Company Projected Revenue Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Company Future Revenue|Projected Sales Volume VYGR (voyagertherapeutics.com)|Company Future Sales Neumora Therapeutics (NMRA)|SCLX - Company Projected Revenue|Company Sales Forecast Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Company Projected Revenue|CGTX - Company Future Sales|IKT (inhibikase.com) - Projected Sales Volume|cassavasciences.com (SAVA) - Company Future Sales|Company Future Sales Volume ASRT (Assertio Therapeutics)|Company Future Sales Coya Therapeutics|Vistagen - Company Future Sales Volume|ovidrx.com (OVID) - Company Expected Sales Volume|Acumen Pharmaceuticals - Projected Sales Volume|Company Expected Sales Volume cervomed.com|ATHE: Projected Sales Volume|Clene Inc - Company Future Revenue|Company Projected Revenue PepGen|JUNS (Jupiter Neurosciences Inc) - Company Projected Revenue Volume|Company Future Sales Volume RLMD (Relmada Corp)|annovisbio.com - Company Revenue Forecast|Company Projected Revenue gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Company Expected Revenue|KLTO - Company Projected Revenue|Company Expected Sales Volume NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Company Projected Revenue|Company Revenue Forecast MTVA|Company Future Sales Volume NRXS|Company Future Sales Volume Helius Medical (HSDT)|Projected Sales Volume PASG|Neuphoria Therapeutics - Company Revenue Forecast|Company Projected Revenue Minerva Neurosciences, Inc. NERV|Projected Sales Volume Athira Pharma ATHA|ADXN: Company Future Sales Volume|Company Expected Sales Volume Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Projected Revenue|Company Expected Sales Volume Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Projected Sales Volume|Company Future Sales Volume Cortigent (CRGT)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Projected Sales Volume CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Company Expected Sales Volume|ELYM - Company Projected Revenue|Company Sales Forecast intracellulartherapies.com (ITCI)|Longboard (LBPH) - Company Projected Revenue|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics